MoranM. The British Regulatory State: High Modernism and Hyper Innovation.Oxford: Oxford University Press;2003
2.
CrinsonI. The Politics of Regulation within the ‘Modernized’ NHS: The Case of Beta Interferon and the ‘Cost-Effective’ Treatment of Multiple Sclerosis. Critical Social Policy2004; 24: 30–49
CalmanK, HineD. A policy framework for commissioning cancer services: A report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales.London: Department of Health;1995
6.
BlackJ. Constructing and contesting legitimacy and accountability in polycentric regulatory regimes. Regulation & Governance2008; 2: 137–64
PowerM. The Risk Management of Everything.London: Demos;2005
9.
AltR. Transformation in the Pharmaceutical Industry: Developing Customer Orientation at Pharma Corp. Paper delivered at 16th Bled E-Commerce Conference - June 9-13, 2003
10.
NovasC. The Political Economy of Hope: Patients’ Organizations, Science and Biovalue. Biosocieties2006; 1: 289–305